Mammalian EGLN genes have distinct patterns of mRNA expression and regulation

Biochemistry and Cell Biology

Volumn 80, Issue 4, 2002, Pages 421-426

  Lieb, Mark E ^a   Menzies, Keon ^a   Moschella, Maria C ^a   Ni, Rujing ^a   Taubman, Mark B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

C2C12; EGLN; Prolyl hydroxylase; SM 20; Vascular smooth muscle

Indexed keywords

CELL CULTURE; GENES; MUSCLE; RNA;

TRANSCRIPTION FACTORS;

BIOCHEMISTRY;

AMIDE; CYCLOHEXAMIDE; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EGLN1 GENE; EGLN2 GENE; EGLN3 GENE; GENE; GENE EXPRESSION REGULATION; HEART; HYPOXIA; MALE; MAMMAL; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; TESTIS; VASCULAR SMOOTH MUSCLE;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0036433394     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o02-115     Document Type: Article

References (16)

1. Aravind, L., and Koonin, E.V. 2001. The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Biol. 2(3): research: 0007.1-0007.8.
2. Dupuy, D., Aubert, I., Duperat,V.G., Petit, J., Taine, L., Stef, M., Bloch, B., and Arveiler, B. 2000. Mapping, characterization, and expression analysis of the SM-20 human homologue, c1orf12, and identification of a novel related gene, SCAND2. Genomics, 69: 348-354.
3. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., Tian, Y.M., Masson, N., Hamilton, D.L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P.H., Pugh, C.W., Schofield, C.J., and Ratcliffe, P.J. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107: 43-54.
4. Green, R.S., Lieb, M.E., Weintraub, A.S., Gacheru, S.N., Rosenfield, C.L., Shah, S., Kagan, H.M., and Taubman, M.B. 1995. Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening. Lab. Invest. 73: 476-482.
5. Hsiao, W.L., Wu, T., and Weinstein, I.B. 1986. Oncogene-induced transformation of a rat embryo fibroblast cell line is enhanced by tumor promoters. Mol. Cell. Biol. 6: 1943-1950.
6. 2 homeostastis by hypoxia-inducible factor 1 alpha. Genes Dev. 12(2): 149-162.
7. 2-regulated prolyl hydroxylation. Science (Washington, D.C.), 292: 468-472.
8. Lipscomb, E.A., Sarmiere, P.D., and Freeman, R.S. 2000. SM-20: A novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 1: 1.
9. Madden, S.L., Galella, E.A., Riley, D., Bertelsen, A.H., and Beaudry, G.A. 1996. Induction of cell growth regulatory genes by p53. Cancer Res. 56: 5384-5390.
10. Marti, H.H., and Risau, W. 1998. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. U.S.A. 95: 15 809-15 814.
11. Moschella, M.C., Menzies, K., Tsao, L., Lieb, M.A., Kohtz, J.D., Kohtz, D.S., and Taubman, M.B. 1999. SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation. Gene Exp. 8: 59-66.
12. Okazaki, H., Majesky, M.W., Harker, L.A., and Schwartz, S.M. 1992. Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ. Res. 71: 1285-1293.
13. Richard, D.E., Berra, E., and Pouyssegur, J. 2000. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275: 26 765-26 771.
14. Taylor, M.S. 2001. Characterization and comparative analysis of the EGLN gene family. Gene, 275: 125-132.
15. Wax, S.D., Rosenfield, C.L., and Taubman, M.B. 1994. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269: 13 041-13 047.
16. Wax, S.D., Tsao, L., Lieb, M.E., Fallon, J.T., and Taubman, M.B. 1996. SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle. Lab. Invest. 74: 797-808.